帕瑟诺利德通过共同向Trim33和抑制NF-κB通路来改善败血症中的炎症
Xueling He1, Chen Wang2, Ruihao Zhang3
1Ningbo Municipal Hospital of TCM Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo 315010, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Guangdong Provincial Key Laboratory of Research and Development in TCM, Guangdong Second Hospital of Traditional Chinese Medicine, Guangzhou 510000, Guangdong, China.
概括
帕瑟诺利德 (PA) 通过向Trim33蛋白,抑制NF-κB通路并减少炎症,有效治疗败血症. 这项研究揭示了PAPA.
科学领域:
- 生物化学和分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是一种危及生命的疾病,是由不受控制的免疫反应引起的感染.
- 作为NF-κB抑制剂的帕氏化物 (PA) 已显示出缓解炎症反应的潜力.
- 了解PA在败血症中的精确抗炎机制对于治疗的发展至关重要.
研究的目的:
- 在败血症模型中研究帕瑟诺利德 (PA) 的抗炎作用.
- 通过化学蛋白质组学来识别PA的功能性蛋白质标.
- 阐明通过PA缓解败血症引起的炎症的分子途径.
主要方法:
- 在小鼠中通过结和刺穿 (CLP) 诱导败血症;在RAW264.7细胞上使用脂聚糖 (LPS) 建模细胞炎症.
- 与酶相关的免疫吸收试验 (ELISA) 和H&E染色评估了PA在体内治疗效果.
- 简化基于氨酸活性的蛋白质概况 (SLC-ABPP) 和蛋白质组学在体外确定了PA的标和途径.
主要成果:
- 在败血症小鼠中,PA治疗改善了生存率,减少了炎症性细胞因子,并改善了组织损伤.
- 在LPS刺激的巨细胞中,PA有效抑制了炎症.
- 化学蛋白组学确定了Trim33作为PA的直接目标,揭示了PA通过稳定Smad4.4来抑制NF-κB通路.
结论:
- 帕瑟诺利德 (PA) 通过向Trim33,抑制Smad4无化,并抑制NF-κB通路来减轻与败血症相关的炎症.
- 这些发现为PA在炎症性疾病的潜在临床应用提供了新的见解.
- 在治疗败血症和相关炎症状况方面,PA显示出显著的治疗潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Gene Regulation in Microbial Communities: Quorum Sensing
740
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
740
Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K


